Navigation Links
Tracking the Battle Against Breast Cancer With New Market Research
Date:1/29/2013

FARMINGTON, Conn., Jan. 29, 2013 /PRNewswire-iReach/ -- Breast cancer is the most diagnosed cancer in women and is the leading cause of death among women globally. Increased public awareness and improved screening have led to earlier diagnosis, significantly improving survival rates, particularly in younger women. Unfortunately, many early breast cancer growths are not associated with pain or discomfort, and therefore are first detected as abnormalities on mammograms before patients or healthcare providers notice them.

(Logo:  http://photos.prnewswire.com/prnh/20130129/CG49640)

Global Information (GII) highlights three market research reports covering the breast cancer market, drug pipeline and partnering deal activities. The reports will help participating organizations benchmark their own developments against worldwide data, compare portfolio and therapy focus with peers, jumpstart competitive drug intelligence operations, and more.

Time is running out to register for the Molecular Med Tri-Con 2013, which will feature conference programs in the following channels: diagnostics, therapeutics, clinical, informatics, and cancer.

Molecular Med Tri-Con 2013| February 11 – 15, 2013 | San Francisco, CA

Visit https://www.giiresearch.com/conference/en/order/246560 to register today

Breast Cancer Drug Pipeline Update 2013

There are currently 351 companies plus partners who are developing 479 drugs targeting breast cancer across 247 different targets. In addition, there are 7 suspended drugs and another 185 drugs where development has been ceased.

This report provides world-wide drug pipeline information, delivered in an unbiased and independent pipeline progress analysis for each identified drug. Breast Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 247 different targets. These targets are further categorized on in the software application by 61 classifications of molecular function and with pathway referrals to BioCarta, KEGG and NetPath.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/bg171732-breast-cancer.html

Breast Cancer Diagnostic and Drug Technologies: Global Markets

The market for predictive diagnostic and drug technologies for breast cancer was valued at $21.2 billion in 2011. This figure is projected to reach nearly $24.1 billion in 2016, a five-year compound annual growth rate (CAGR) of 2.5%.

Breast cancer drugs accounted for $10.2 billion in 2011 and should total $11.2 billion in 2016, a CAGR of 1.9%. Quantitative immunofluorescence totaled $5.9 billion in 2011 and should reach $6.9 billion in 2016, a CAGR of 3.1%. Genomic analysis was worth $4.4 billion in 2011 and in 2016 should be worth nearly $5.2 billion, a CAGR of 3.1%. IHC and FISH accounted for nearly $678 million in 2011 and are expected to be worth nearly $788 million in 2016, a CAGR of 3.1%.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/bc245536-breast-cancer-diagnostic-drug-technologies-global.html

Breast Cancer Partnering 2007-2012

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This report provides an analysis of breast cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors breast cancer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/wild233895-breast-cancer-partnering-2007-2012.html

For more market research highlights, technical research news and industry updates, please visit http://www.giiresearch.com/press/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Precision motion tracking Thousands of cells at a time
2. Precision motion tracking - Thousands of cells at a time
3. Clinical technique sets new standard for speed in battle to prevent pandemic infection
4. Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
5. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
6. MU researchers identify key plant immune response in fight against bacteria
7. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
8. Nanosurgery and the fight against cancer: Major breakthrough at Polytechnique Montral
9. 3M Withdraws Blackmail Claims Against Harvey Boulter From New York Court
10. Defending against chemical acts of terrorism
11. X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHIs Protein Engineering Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces ... the secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment ... PROMPT study, which seeks to advance understanding of the hereditary risks for certain ...
(Date:2/9/2016)... ... February 09, 2016 , ... With a presidential election in November ... Business Conference will bring together over 500 top healthcare leaders for a night and ... The conference, organized by MBA students of the University of Pennsylvania’s Wharton School, will ...
(Date:2/9/2016)... ... February 09, 2016 , ... Tunnell Consulting, Inc. announced that Frédéric Lefebvre ... will focus on acquiring new accounts and work closely with existing Tunnell clients throughout ... brings to our European clients more than 15 years of experience in the pharmaceutical ...
(Date:2/9/2016)... This market research report on the global ... of the market in terms of revenue (USD Million). ... the manufacture of microbiology culture media and related products. ... snapshot providing the overall information of various market segments ... also provides the overall information and data analysis of ...
Breaking Biology Technology:
(Date:2/3/2016)... Calif. , Feb. 3, 2016 Vigilant ... Police Department in Missouri ... license plate reader (LPR) data from Vigilant Solutions. ... hit-and-run case in which the victim was walking out of a convenience ... parking space next to his vehicle, striking his vehicle ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
Breaking Biology News(10 mins):